The Brazil generic drug market size reached USD 22.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The Brazil market is primarily driven by growing government support, cost-effectiveness appealing to diverse economic demographics, a growing aging population with escalating healthcare needs, and substantial pharmaceutical investments enhancing local production.
Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. According to estimates, around BRL 2 Billion worth of branded drugs are expected to lose patent protection during the next five years. The high potential of generic drugs is also driven by the fact that despite strong growth in recent years, the penetration of generics still remains low compared to mature markets such as Germany, the United States, the United Kingdom, etc. These factors along with a rising ageing population, increasing prevalence of life style diseases and the significant cost savings achieved from the use of generic drugs are expected to drive this market in the coming years.
The report entitled “Brazil Generic Drug Market: Industry Trends, Share, Size, Growth, Forecast and Opportunity 2025-2033” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Brazil. This research report serves as an exceptional tool to understand the drivers, sales trends, volume trends, market structure, competitive landscape, regulations, key players, manufacturing and the outlook of generic drugs in Brazil. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the market for generic drugs in Brazil.
Key Questions Answered in This Report: How has the Brazil generic drug market performed so far, and how will it perform in the coming years?
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Brazil Generic Drug Market - Introduction
- 4.1 What are Generic Drugs?
- 4.2 Classification of Generic Drugs
- 5 Why is the Brazil Generic Drug Market So Lucrative
- 5.1 Drug Patent Expiries
- 5.2 Lower Costs
- 5.3 Government Support
- 5.4 Increasing Consumer Confidence
- 5.5 Increasing Access to Generic Drugs
- 5.6 High Growth Potential for Biosimilar Drugs
- 6 Global Generic Drug Market
- 6.1 Generic Drug Market Performance
- 6.1.1 Value Trends
- 6.1.2 Volume Trends
- 6.2 Market Breakup by Country
- 6.3 Most Prescribed Generic and Branded Drugs
- 6.4 Market Forecast
- 7 Brazil Generic Drug Market
- 7.1 Brazil Pharmaceutical Market Performance
- 7.1.1 Value Trends
- 7.1.2 Volume Trends
- 7.1.3 Market Breakup by Type
- 7.1.4 Market Forecast
- 7.2 Brazil Generic Drug Market Performance
- 7.2.1 Value Trends
- 7.2.2 Volume Trends
- 7.2.3 Impact of COVID-19
- 7.2.4 Market Forecast
- 8 Brazil Generic Drug Industry: SWOT Analysis
- 8.1 Overview
- 8.2 Strengths
- 8.3 Weaknesses
- 8.4 Opportunities
- 8.5 Threats
- 9 Brazil Generic Drug Industry: Value Chain Analysis
- 9.1 Research and Development
- 9.2 Manufacturing
- 9.3 Marketing
- 9.4 Distribution
- 9.5 Pricing
- 10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
- 11 Brazil Generic Drug Industry: Porter’s Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
- 12 Brazil Generic Drug Market: Competitive Landscape
- 12.1 Brazil Generic Drug Market: Competitive Structure
- 12.2 Brazil Generic Drug Market: Market Share of Key Players
- 12.3 Distribution Channels
- 13 Government Policy
- 14 Brazil Generic Drug Market: Key Success Factors
- 15 Brazil Generic Drug Market: Road Blocks
- 16 Generic Drug Manufacturing Process
- 16.1 Manufacturing Process
- 16.2 Raw Material Requirements
- 16.3 Raw Materials Pictures
- 16.4 Land and Construction Requirements
- 16.5 Machinery and Infrastructure Requirements
- 16.6 Machinery Pictures
- 16.7 Plant Layout
- 16.8 Packaging Requirements
- 16.9 Utility Requirements
- 16.10 Manpower Requirements
- 17 Brazil Generic Drug Market: Key Company Profiles
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook